Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers

Immunotherapy has revolutionized the treatment paradigm of non-small cell lung cancer and improved patients’ prognosis. Immune checkpoint inhibitors have quickly become standard frontline treatment for metastatic non-oncogene addicted disease, either as a single agent or in combination strategies. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Russano, Marco, La Cava, Giulia, Cortellini, Alessio, Citarella, Fabrizio, Galletti, Alessandro, Di Fazio, Giuseppina Rita, Santo, Valentina, Brunetti, Leonardo, Vendittelli, Alessia, Fioroni, Iacopo, Pantano, Francesco, Tonini, Giuseppe, Vincenzi, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955173/
https://www.ncbi.nlm.nih.gov/pubmed/36826142
http://dx.doi.org/10.3390/curroncol30020181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955173/
https://www.ncbi.nlm.nih.gov/pubmed/36826142
http://dx.doi.org/10.3390/curroncol30020181

Ejemplares similares